Mandate

Vinge advised Nordion Energi AB in connection with its acquisition of all shares in Falbygden Energi AB

January 01, 2021 M&A

Vinge is advising Nordion Energi AB in connection with its acquisition of all shares in Falbygden Energi AB (“FEAB”) from Infracapital, the Infrastructure equity investment arm of M&G Plc.

Nordion Energi AB currently consists of Swedegas, the sole gas TSO  in Sweden, and Weum, the largest gas DSO operating 1,927km of distribution pipelines. Nordion Energi AB is owned by the European Diversified Infrastructure Fund (EDIF II), which is managed by First Sentier Investors (formerly First State Investments), a global investment management company with more than 20 years’ experience of infrastructure investments. 

FEAB supplies electricity, heat and fibre broadband to customers in the municipality of Falköping. FEAB's district heating network is supplied by 100% renewable energy and was marked 'Good Environmental Choice' by the Swedish Society for Nature Conservation. The company operates an electricity network of over 2,200 km with over 17,000 customers. 

The Vinge team advising on the transaction includes partners Christoffer Thalin (lead), Anna Edström, Peter Sundgren, Carl-Johan af Petersens, Johan Cederblad and Pär Remnelid  with the associates Niklas Törnell, Christina Odengran, Fredrik Christiansson, Julia Söderdahl, Philip Åberg, Helena Brännvall, Isabell Nielsen, Lova Unge, Erik Lagerlöf, Kristoffer Larson, Hedvig Ekdahl, Lisa Hörnqvist, Jonathan Riddersholm and Lina Österberg.   

Related

Vinge has advised Eleda in connection with Eleda Norge AS’s acquisition of Nettpartner Bane AS

Vinge, together with Advokatfirmaet Thommessen, has advised Eleda in connection with Eleda Norge AS’s acquisition of Nettpartner Bane AS from Å Energi owned Nettpartner AS.
January 19, 2026

Vinge advises KEYTO Group in connection with the acquisition of Smartify

KEYTO Group continues its growth journey by strengthening its offering in Sweden as Smartify Sverige AB joins KEYTO Group.
January 19, 2026

Vinge has advised Orexo in connection with the divestment of the US rights to Zubsolv

Vinge has advised Orexo in relation to Swedish law in connection with the divestment of the US rights to Zubsolv to Dexcel Pharma USA.
January 14, 2026